# Sevoflurane Induced Emergence Agitation

> **NCT02022488** · PHASE4 · COMPLETED · sponsor: **Yeditepe University Hospital** · enrollment: 78 (actual)

## Conditions studied

- Emergence Agitation

## Interventions

- **DRUG:** midazolam
- **DRUG:** alfentanil
- **DRUG:** ketamine

## Key facts

- **NCT ID:** NCT02022488
- **Lead sponsor:** Yeditepe University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2013-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02022488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02022488, "Sevoflurane Induced Emergence Agitation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02022488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*